Tenax Therapeutics (TENX) Other Operating Expenses: 2011-2016
- Tenax Therapeutics' Other Operating Expenses was N/A to $33.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $34.9 million, marking a year-over-year change of. This contributed to the annual value of $33.3 million for FY2016, which is N/A change from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' Other Operating Expenses is $33.3 million, which was up 3,114.44% from $1.0 million recorded in Q2 2015.
- Tenax Therapeutics' Other Operating Expenses' 5-year high stood at $33.3 million during Q4 2016, with a 5-year trough of $29,534 in Q2 2012.
- For the 2-year period, Tenax Therapeutics' Other Operating Expenses averaged around $17.1 million, with its median value being $17.1 million (2015).
- Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 90.22% in 2012, then surged by 1,971.12% in 2013.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Other Operating Expenses stood at $29,534 in 2012, then surged by 1,971.12% to $611,685 in 2013, then reached $1.0 million in 2015, then reached $33.3 million in 2016.
- Its Other Operating Expenses was $33.3 million in Q4 2016, compared to $1.0 million in Q2 2015 and $611,685 in Q2 2013.
